Study on postprandial glycemic response of Glucomeal in type 2 diabetes

Phase 1

Completed

• Conditions: type 2 diabetes; T2DM

• Registration Number: TCTR20190917004
• Lead Sponsor: Mega Lifesciences Public Company Limited

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-09-17
• Study Completion: 2020-08-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1.BMI 18.5-30 kg-m2
2.Only stable oral hypoglycemic drugs for at least 2 months.

Exclusion Criteria

1. Concomitant therapy insulin
2. Person with gastrointestinal disease, renal disease, liver disease, thyroid disease, cancer, cardiovascular disease
3. Pregnant or lactating females.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
postprandial glycemic control Before taking intervention meal (0 min). And at 30, 60, 90, 120, 180 and 240 minutes after consuming Blood sugar

Secondary Outcome Measures

Name	Time	Method
postprandial insulin response Before taking intervention meal (0 min). And at 30, 60, 90, 120, 180 and 240 minutes after consume. Insulin,postprandial active-GLP-1 response Before taking intervention meal (0 min). And at 30, 60, 90, 120, 180 and 240 minutes after consuming Active-GLP-1